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Genetic Analysis of the Herpes Simplex Virus Type 1 UL20 Protein
Domains Involved in Cytoplasmic Virion Envelopment and
Virus-Induced Cell Fusion
Jeffrey M. Melancon, Timothy P. Foster, and Konstantin G. Kousoulas*
Division of Biotechnology and Molecular Medicine, School of Veterinary Medicine, Louisiana State
University, Baton Rouge, Louisiana 70803

The herpes simplex virus type 1 UL20 protein (UL20p) is an important determinant for cytoplasmic virion
morphogenesis and virus-induced cell fusion. To delineate the functional domains of the UL20 protein, we
generated a panel of single and multiple (cluster) alanine substitutions as well as UL20p carboxyl-terminal
truncations. The UL20 mutant genes could be broadly categorized into four main groups: Group I UL20
mutant genes complemented for both virus production and virus-induced cell fusion; Group II UL20 mutant
genes did not complement for either virus-induced cell fusion or infectious virus production; Group III UL20
mutant genes complemented for virus-induced cell fusion to variable extents but exhibited substantially
decreased ability to complement UL20-null infectious virus production; Group IV mutant genes complemented
for infectious virus production but had variable effects on virus-induced cell fusion; this group included two
mutants that efficiently complemented for gBsyn3, but not for gKsyn1, virus-induced cell fusion. In addition,
certain recombinant viruses with mutations in either the amino or carboxyl termini of UL20p produced
partially syncytial plaques on Vero cells in the absence of any other virally encoded syncytial mutations. These
studies indicated that the amino and carboxyl termini of UL20p contained domains that functioned both in
infectious virus production and virus-induced cell fusion. Moreover, the data suggested that the UL20p’s role
in virus-induced cell fusion can be functionally separated from its role in cytoplasmic virion morphogenesis
and that certain UL20p domains that function in gB-syn3 virus-induced cell fusion are distinct from those
functioning in gKsyn1 virus-induced cell fusion.
capsids into trans-Golgi network (TGN)-derived vesicles. This
final event in cytoplasmic virion envelopment is thought to be
mediated by interactions between tegument proteins and cytoplasmic portions of viral glycoproteins embedded within the
TGN-derived membranes. Cytoplasmically enveloped viruses
are thought to be transported to extracellular spaces within
Golgi or TGN-derived vesicles (reviewed in references 25, 31,
and 41).
The UL20 gene encodes a 222-amino-acid nonglycosylated
transmembrane protein that is conserved by all alphaherpesviruses. The UL20p is a structural component of extracellular
enveloped virions, and it is expressed in infected cells assuming
a predominantly perinuclear and cytoplasmic distribution (44).
A partial deletion of the UL20 gene was reported to form
weakly syncytial viral plaques in certain cell types and severe
defects in cytoplasmic virion envelopment, implying that UL20
functioned in virus-induced cell fusion and virion morphogenesis. Furthermore, replication of the UL20-null virus could be
partially complemented in certain cell types indicating a cellular specificity of UL20 functions (6). This UL20p cellular specificity was phenomenologically associated with disruption of
the Golgi apparatus during viral infections, inasmuch as cells
that complemented the UL20-null virus retained intact Golgi
networks, whereas the Golgi networks of cells failing to complement the UL20-null virus were disrupted and dispersed
throughout the cytoplasm (4, 5).
Recently, it was shown that a precise deletion of the UL20
gene caused accumulation of unenveloped capsids into the
cytoplasm, indicating that the HSV-1 UL20p functioned in

Herpes simplex viruses (HSV) specify at least 11 virally
encoded glycoproteins, as well as several nonglycosylated
membrane-associated proteins, most of which play important
roles in multiple membrane fusion events during virus entry
and intracellular virion morphogenesis and egress (34, 37–39).
Spread of infectious virus occurs either by release of virions to
extracellular spaces or through virus-induced cell-to-cell fusion. Mutations that cause extensive virus-induced cell fusion
arise predominantly in four genes of the HSV genome: the
UL20 gene (6, 28), the UL24 gene (23, 36), the UL27 gene
encoding glycoprotein B (gB) (10, 32), and the UL53 gene
coding for glycoprotein K (gK) (8, 12, 21, 33, 35). Of these four
membrane-associated proteins, only UL20 and gK are essential for the intracellular transport of virions to extracellular
spaces in all cell types (6, 16, 18, 22, 24).
Virus morphogenesis and egress of infectious herpes virions
is thought to involve sequential de-envelopment and reenvelopment steps in transit to extracellular spaces as follows: (1)
primary envelopment by budding of capsids assembled in the
nuclei through the inner nuclear leaflet leading to the production of enveloped virions within perinuclear spaces; (ii) deenvelopment by fusion of viral envelopes with the outer nuclear leaflet leading to the accumulation of unenveloped
capsids in the cytoplasm; (iii) reenvelopment of cytoplasmic
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cytoplasmic stages of virion envelopment and that the previously reported partial deletion of the UL20 gene caused a
predicted fusion of the UL20p to the adjacent UL20.5 gene. In
addition, syncytial mutations in either gB or gK failed to cause
fusion in the absence of the UL20 gene, suggesting that the
UL20 protein was essential for virus-induced cell fusion (17).
Furthermore, it was shown that UL20 is required for cell surface expression of gK, suggesting a functional interdependence
between gK and UL20 for virus egress and cell-to-cell fusion
(14, 15, 17). In this study we have delineated via site-directed
mutagenesis the functional domains of UL20p involved in infectious virus production and virus-induced cell fusion. Importantly, we show that both amino- and carboxyl-terminal portions of UL20p, which are predicted to lie within the
cytoplasmic side of cellular membranes, function both in cytoplasmic virion envelopment and virus-induced cell fusion.
Overall, the data suggest that UL20p’s role in virus-induced
cell fusion can be functionally separated from its role in cytoplasmic virion morphogenesis and that certain UL20p domains
that function in gB-syn3 virus-induced cell fusion are distinct
from those functioning in gKsyn1 virus-induced cell fusion.
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero) cells were obtained
from the American Type Culture Collection (Rockville, Md.). The Vero-based
UL20 complementing cell line, G5, was a gift of P. Desai, (John Hopkins Medical
Center) (13). Cells were maintained as previously described (13, 15, 16). The
parental wild-type strain used in this study, HSV-1(KOS), was originally obtained
from P. A. Schaffer (Harvard Medical School). Flp-In-CV-1 cells were maintained as directed by the manufacturer (Invitrogen, Inc.). ⌬20DIV5, ⌬20gBsyn3,
and ⌬20syn20DIV5 viruses were as described previously (17), and virus stocks
were grown on Fd20-1 cells, described below. In this paper, for simplification
purposes, the ⌬20DIV5 virus is referred to as ⌬20 virus and the ⌬20syn20DIV5
virus is referred to as ⌬20gKsyn1 virus (the syn20 and syn1 mutation are the
same, Ala-to-Val at gK amino acid 40).
Construction of transformed Flp-In-CV-1 cell lines. Generation of stable
Flp-In-CV-1 expression cell lines was performed essentially as directed by the
manufacturer (Invitrogen). Briefly, confluent Flp-In-CV-1 monolayers in six-well
plates were transfected by using Lipofectamine 2000 with 0.3 g of either
pcDNA5/FRT/UL20 or pFRT/gDpro/UL20 and 2.7 g of pOG44 (Invitrogen),
which expresses Flp recombinase. After 2 weeks, hygromycin B (125 g/ml)resistant colonies were tested for the ability to complement the growth of ⌬20,
⌬20gBsyn3, and ⌬20gKsyn1 viruses. All colonies derived from each plasmid
complemented UL20-null virus. Isolates Fc20-1 and Fd20-1, derived from
pcDNA5/FRT/UL20 and pFRT/gDpro/UL20 transfected cells, respectively,
were chosen for further use. Fd20-1 cells were used in generating UL20-null virus
stocks.
Plasmids. pCR2.1-UL20, which was used as the parental vector for UL20
mutagenesis, was generated by cloning a 773-bp DNA fragment containing the
UL20 gene, obtained by PCR amplification of HSV-1(KOS) viral DNA, into
pCR2.1/TOPO (Invitrogen). A 7,185-bp fragment spanning the region comprising UL19, UL20, UL21, and UL22 was PCR amplified from KOS virus DNA by
using primers p20F2 5⬘ (TTTCTTGAATTCACGACGGCGGTGTAGCCC
ACG) and p20F2 3⬘ (CTTCTTGAATTCCCCATCACCCACAACGCCAGC),
restricted by EcoRI, and ligated into puc19BX (17) to generate p20F2. p20F2
was modified by silencing the BamHI site at genomic nucleotide position 39235
(GenBank accession number NC_001806), conserving the UL19 amino acid
sequence, and removing a 767-bp BamHI DNA fragment containing the UL20
gene, resulting in plasmid p20F2BX (see Fig. 2D). UL20 cluster-to-alanine
mutants, single point mutants, and truncation mutants were generated by two
methods. Mutants CL11, CL23, CL34, CL38, CL121, CL209, 66t, and 149t were
generated by using the GeneTailor Site-Directed Mutagenesis kit as directed by
the manufacturer (Invitrogen). Mutants CL5, CL16, CL30, CL41, CL46, CL49,
CL153, CL173, CL177, 181t, 204t, 211t, 216t, Y49A, S50A, R51A, D123A,
R209A, T212A, and R213A were generated by splice-overlap extension PCR (1).
Mutant UL20 genes were transferred into the BamHI site of the vector
p20F2BX. All p20F2BX mutant constructs were sequenced to verify error free
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mutagenesis. Plasmid p20R contains a wild-type UL20 gene cloned into
p20F2BX. An additional plasmid was constructed from p20F2BX, designated
p⌬20NE, to include the same UL20 deletion as p⌬20-EGFP (17) without the
EGFP gene cassette. Plasmid pcDNA5/FRT/UL20 was constructed by inserting
the UL20 gene, which had been PCR amplified from KOS viral DNA, into
pcDNA5/FRT/V5-His-TOPO (Invitrogen). An additional plasmid, pFRT/gDpro/
UL20, was constructed by replacing the cytomegalovirus (CMV) promoter in
pcDNA5/FRT/UL20 with the HSV-1 KOS gD promoter region.
UL20 complementation assay for infectious virion production. The complementation assay was modified from a similar assay described previously (7).
Confluent Vero monolayers in six-well plates were transfected with 1.5 g of
pcDNA3.1/V5-His-TOPO/lacZ (Invitrogen), expressing ␤-galactosidase under
control of the CMV promoter, and 1.5 g of wild-type or mutant UL20 plasmid
with Lipofectamine 2000 as described by the manufacturer (Invitrogen). Six
hours posttransfection, the monolayers were infected with a UL20-null virus at a
multiplicity of infection (MOI) of 1. Infections were placed on a rocker for 1 h
at 4°C and then transferred to 37°C for 2 h. Residual virus was inactivated by
using an acid wash (phosphate-buffered saline containing 0.5 M glycine, pH 3)
for 2 min, and monolayers were subsequently washed three times with Dulbecco’s modified Eagle’s medium to restore the pH to a normal level. Infections
were incubated at 37°C for 24 h. After repeated freeze-thaw cycles, the titers of
virus stocks were determined in triplicate on G5 cells, which effectively complement the UL20-null defect (17). An aliquot of each virus stock was saved to assay
for ␤-galactosidase expression as described below.
␤-Galactosidase expression levels were quantified essentially as described previously (7). One hundred microliters of Z buffer containing 0.27% ␤-mercaptoethanol and 0.2% Triton X-100 was added to 100 l of virus stock and vortexed
for 30 s. Cell debris was pelleted by centrifugation at 16,100 ⫻ g in a microcentrifuge for 30 s. One hundred sixty microliters of the supernatant was transferred
to a 96-well plate and allowed to react with 40 l of 4 mg of ONPG (nitrophenyl-␤-D-galactopyranoside) stock/ml at room temperature. The reactions were allowed to proceed for 90 min before absorbance at 405 nm was
determined.
Calculation of complementation ratios. The complementation ratio for each
mutant was calculated with the following formula: [(virus titer of mutant/virus
titer of negative control)⫻(experimental ␤-galactosidase value/␤-galactosidase
value of negative control)]. With this formula, values obtained from the ␤-galactosidase assay were used to correct for minor differences in transfection
efficiency; the complementation ratio for the negative control (plasmid p⌬20NE)
was set at 1.
UL20 complementation assay for virus-induced cell-to-cell fusion. Confluent
Vero monolayers in six-well plates were transfected with 3 g of wild-type or
mutant UL20 plasmid with Lipofectamine 2000 as described by the manufacturer
(Invitrogen). Eighteen hours posttransfection, the monolayers were infected at
an MOI of 0.1 with either ⌬20gKsyn1 or ⌬20gBsyn3 viruses. Infections were
placed on a rocker at room temperature for 1 h and then transferred to 37°C for
30 min. Cells were overlaid with Dulbecco’s modified Eagle’s medium containing
1% methylcellulose. Twenty-four hours postinfection (h.p.i.), cell fusion was
determined by visualization of syncytia formation by fluorescence microscopy.
Cell fusion was blindly scored by two independent observers, and scores were
linked to individual mutants after the cell fusion scoring was completed. Cell
fusion was scored as completely absent (⫺), present at very low levels (⫹),
present at moderate levels (⫹⫹), or present at levels near (⫹⫹⫹) or equivalent
to (⫹⫹⫹⫹) those observed when the wild-type UL20 gene was used. The score
of (⫺) indicates no syncytial formation as evidenced by the absence of cells
having more than one nucleus. The score of (⫹) indicates the presence of
syncytia containing on the average five nuclei or fewer. The score of (⫹⫹)
reflects syncytia containing 6 to 10 nuclei per cell. The score of (⫹⫹⫹) is
assigned to 11 to 20 nuclei per cell. The score of (⫹⫹⫹⫹) is for syncytia having
⬎20 nuclei per cell.
Electron microscopy. Cell monolayers were infected with the indicated virus at
an MOI of 5. All cells were prepared for transmission electron microscopy
(TEM) examination 24 h p.i. Infected cells were fixed in a mixture of 2%
paraformaldehyde and 1.5% glutaraldehyde in 0.1 M NaCaC buffer, pH 7.3.
Following osmication (1% OsO4) and dehydration in an ethanol series, the
samples were embedded in Epon-Araldyte resin and polymerized at 70°C. Thin
sections were made on an MTXL Ultratone (RMC Products), stained with 5%
uranyl acetate and CNA lead, and observed with a Zeiss 10 transmission electron
microscope as described previously (15).
Generation of recombinant viruses specifying mutant UL20p. Viruses that
contained the UL20 mutations were generated by rescuing the UL20-null viruses
(⌬20, ⌬20gBsyn3, and ⌬20gKsyn1) with plasmids containing the desired UL20
mutant genes bracketed by adjacent viral sequences to facilitate homologous
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TABLE 1. Amino acid sequences of mutations
Mutation or
truncation

Mutations
CL5
CL11
CL16
CL23
CL30
CL34
CL38
CL41
CL46
CL49
Y49A
S50A
R51A
CL121
CL153
E153A
T154A
S156A
D158A
CL173
CL177
CL209
R209A
T212A
R213A
Truncations
66t
149t
181t
204t
211t
216t
a

Domain

I
I
I
I
I
I
I
I
I
I
I
I
I
III
IV
IV
IV
IV
IV
IV
IV
V
V
V
V

Amino acid sequence
Wild type

DD
DRD
DE
EEGE
EE
SLSS
YGT
SD
SS
YSR
YAR
KRDR
ETFSPD

TD
RTR
RFWTR

VILFL
LFAAA
RALGI
SANFF
RFWTR
AILNA

Mutanta

AA
AAA
AA
AAGA
AA
ALAA
AGA
AA
AA
AAA
ASR
YSA
AADA
AAFAPA
ATFSPD
EAFSPD
ETFAPD
ETFSPA
AA
AAA
AFWAA
AFWTR
RFWAR
RFWTA
VILG*
LFAG*
RALG*
SANG*
RFWG*
AILG*

*, stop codon.

recombination with the viral genome (see Fig. 3). Briefly, confluent Vero cell
monolayers were transfected with each plasmid, and transfected cells were infected with the ⌬20 virus 6 h after transfection. Virus stocks were prepared at
48 h.p.i., and recombinant viruses were plaque isolated on Vero cells and sequentially plaque purified at least five times. Replacement of the UL20-null
resident CMV-enhanced green fluorescent protein (EGFP) gene cassette and
the concomitant insertion of the mutated UL20 gene were confirmed by DNA
sequencing. Visualization of viral plaques was achieved by either phase contrast
microscopy or immunohistochemistry essentially as described previously (17).

RESULTS
Mutagenesis of HSV-1 UL20. To delineate the functional
domains of UL20p required for infectious virus production,
virus egress, and virus-induced cell fusion, we constructed a
panel of 31 mutations within the UL20 gene by site-directed
mutagenesis. These mutations included (i) cluster-to-alanine
mutants in which a cluster of proximal amino acids were
changed to alanine residues, (ii) single-amino-acid replacement mutants within alanine cluster regions, and (iii) carboxylterminal truncations of UL20p. The mutated amino acids for
each type of mutation are shown in Table 1. The carboxylterminal truncations are identified by the number of the last
remaining amino acid (i.e., 66t retains UL20p amino acids 1 to
66). To facilitate placement of each mutation on the predicted
luminar or cytoplasmic portions of UL20p, the hydrophobic
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and membrane-spanning domains of UL20p were calculated
by using the TMPred and SOSUI computer algorithms (19, 20)
and used to derive a predicted membrane spanning model of
UL20p (Fig. 1). This UL20p model features four membranespanning regions placing both amino and carboxyl termini of
UL20p within the cytoplasm (Domains I and V). In addition, a
third small domain is located intracellularly (domain III), while
the two other domains are located extracellularly (domains II
and IV). The predicted membrane topology of UL20p was
used as the guide for selecting alanine scanning mutations
within predicted intracellular and extracellular domains of
UL20p. Regions containing clusters of charged amino acids as
well as potential phosphorylation sites were specifically targeted. The location of each cluster mutation is marked on the
UL20p model, starting with the first mutated amino acid of the
cluster (Fig. 1; Table 1).
Complementation assay for infectious virus production. It
was previously shown that deletion of the HSV-1 UL20 and the
PRV UL20 genes resulted in a reduction of up to two logs in
infectious virus production relative to their parental wild type
strains (6, 17, 18). To delineate functional domains of the
UL20 protein involved in infectious virus production, each of
the 31 mutated UL20 genes was tested for its ability to complement the HSV-1(KOS) UL20-null virus. The mutated genes
were cloned into plasmids under their own promoter control
bracketed by upstream and downstream DNA sequences to
facilitate complementation experiments as well as isolation of
recombinant viruses (Fig. 2D and E) (see Materials and Methods). Complementation experiments involved transfection of
Vero cells with plasmids encoding wild-type or mutant UL20
genes, followed by infection with the UL20-null virus (17). A
complementation ratio was calculated for each mutant UL20
plasmid, p20R (wild-type UL20, positive control), and
p⌬20NE (UL20-null mutation, negative control). The complementation ratio of p⌬20NE was set to 1 for each experiment.
The complementation ratios for the UL20 cluster mutants and
truncation mutants are shown in Fig. 3A. Mutants CL5, CL11,
CL16, CL23, CL30, CL34, CL38, CL41 CL46, CL121, CL173,
CL177, and CL209 complemented the UL20-null virus to a
variable extent in comparison to the positive plasmid control
p20R and the negative plasmid control p⌬20NE (Fig. 3A).
Mutants CL49, CL153, 66t, 149t, 181t, 204t, 211t, and 216t
failed to efficiently complement the UL20-null defect in infectious virion production producing complementation ratios similar to those of plasmid p⌬20NE (negative control), indicating
that the mutated UL20 protein was not able to function properly in virus egress (Fig. 3A). To delineate the specific amino
acids responsible for the UL20-associated defects identified by
the cluster mutations, we examined the complementation ratios of several point mutants within cluster regions. The CL49
(YSR-to-AAA; Table 1) mutant UL20 gene failed to efficiently
complement the ⌬20 virus. The Y49A mutant gene, which
involves the Y residue within the CL49 target sequence, produced a complementation ratio similar to that of CL49, while
the adjacent S50A and R51A mutant genes complemented
infectious virus production to nearly wild-type levels (Fig. 3B).
These results indicate that the mutation of the Y residue is
responsible for the complementation defect exhibited by the
UL20 gene carrying the CL49 mutation. In contrast, the UL20
genes carrying the E153A, T154A, S156A, and D158A muta-
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FIG. 1. Predicted membrane topology of UL20p and location of the 15 cluster-to-alanine mutations. Membrane topology was predicted by
using the TMPred and SOSUI algorithms (19, 20). UL20p domains where cluster-to-alanine mutations are located are indicated by a shaded oval.
The naming of cluster mutations is based on the first amino acid mutated in each cluster. TM, transmembrane region; CL, cluster mutant.

tions complemented the UL20-null virus at a greater level than
did the gene with the CL153 mutation, indicating that these
amino acids were not individually responsible for the lack of
complementation by the UL20 gene carrying the CL153 mutation (Fig. 3C). The CL209 UL20 mutant gene as well as
mutant genes carrying individual amino acid changes within
the CL209 target sequence efficiently complemented ⌬20 infectious virus production (Fig. 3D).
Complementation for virus-induced cell-to-cell fusion. Recently, we showed that syncytial mutations in either gB or gK
failed to cause virus-induced cell fusion in the absence of the
UL20 gene (17). Therefore, the panel of 31 UL20 mutants was
tested for the ability to complement UL20-null viruses containing syncytial mutations in either gB (syn3) or gK (syn1) for
virus-induced cell fusion. Confluent Vero monolayers were
transfected with plasmids encoding either wild-type or mutant
UL20p and subsequently infected with either ⌬20gKsyn1 or
⌬20gBsyn3 viruses. These viruses contain a CMV-EGFP gene
cassette in place of the UL20 gene, which facilitates visualization of syncytia formation by fluorescence microscopy (17).
Cell fusion was scored by two observers as detailed in Materials and Methods. Complementation results are summarized

in Table 2, and select mutant phenotypes are displayed in Fig.
4.
UL20 genes carrying the CL5, CL11, CL16, CL23, CL30,
CL34, CL173, CL177, and CL209 mutations produced syncytia
at levels similar to those produced by the positive-control plasmid p20R containing the wild-type UL20 gene. Syncytia formation was completely absent in complementation assays with
UL20 genes specifying the CL153 mutation and all UL20p
carboxyl-terminal truncations (66t, 149t, 181t, 204t, and 211t)
except the 216t truncation, which complemented virus-induced
cell fusion (Fig. 4E, G, and I; Table 2). Other UL20 mutations
had various phenotypes with regard to the extent of syncytia
formation (Table 2). As with the infectious virion production
assay, the phenotype produced by the CL49 mutation was
similar to that of Y49A, but not S50A or R51A (Fig. 4D, F, H,
and J; Table 2). Most mutant UL20 genes were either able or
unable to complement both ⌬20gBsyn3 and ⌬20gKsyn1 viruses, although the level of complementation varied among the
different UL20 mutant genes. However, the CL41 and CL46
mutant UL20 genes efficiently complemented gBsyn3, but not
gKsyn1, virus-induced cell fusion, indicating that these mutations had a differential effect of gBsyn3 versus gKsyn1-induced
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FIG. 2. Schematic representation of the strategy for the construction of UL20-mutant genes used for complementation and isolation of
recombinant viruses. (A) The top line represents the prototypic arrangement of the HSV-1 genome with the unique long (UL) and unique short
(US) regions flanked by the terminal repeat (TR) and internal repeat (IR) regions. (B) Expanded genomic region of the UL20-null virus between
map units 0.239 and 0.305 containing the UL19, CMV-EGFP, UL20.5, UL21, and UL22 genes. (C) The p20F2BX-UL20mut plasmid shows the
expression and recombination plasmids used for complementation assays and construction of the recombinant viruses carrying each UL20
mutation. (D and E) Mutated UL20 genes were inserted into the BamHI restriction site of p20F2BX.

cell fusion (Table 2). The CL38 mutation, which is immediately
proximal to the CL41 mutation, had an obvious defect in
complementation for both gBsyn3 and gKsyn1-induced cell
fusion (Fig. 4C; Table 2).
Plaque phenotypes of ⌬20gBsyn3 and ⌬20gKsyn1 recombinants containing selected UL20 mutations. To further investigate the ability of UL20 mutant genes to complement for
virus-induced cell fusion caused by the gBsyn3 or gKsyn1 virally encoded mutations, specific recombinant viruses expressing UL20p mutant genes were isolated by rescue of the UL20
gene deletion of the ⌬20gBsyn3 and ⌬20gKsyn1 viruses. Recombinant viruses were identified by a lack of EGFP expression on Vero cells. Viral plaques produced by each recombinant virus were characterized as small plaques if they
contained on the average no more than 75 cells or as large
plaques if they contained more than 250 cells per plaque. As
expected, we were unable to isolate recombinants expressing
the CL153, 66t, 149t, 181t, 204t, or 211t mutations on Vero
cells, whereas rescue with the wild-type UL20 gene resulted in
viruses that formed large syncytial plaques similar to the viruses carrying the gBsyn3 or gKsyn1 mutations alone (Fig. 5A
and G). Recombinant viruses carrying the gKsyn1 mutation
and either the CL41 or CL46 UL20 mutation produced small
syncytial plaques on Vero cells (Fig. 5C and D), whereas the
recombinant viruses carrying the gBsyn3 mutation and either
the CL41 or the CL46 mutation produced large syncytial

plaques on Vero cells (Fig. 5I and J). Recombinant viruses
containing the CL38 mutation (Fig. 5B and H) or the CL49
mutation (Fig. 5E and K) in the gBsyn3 or gKsyn1 genetic
background produced significantly smaller syncytial plaques
than the gBsyn3 or gKsyn1 viruses specifying the wild-type
UL20 gene. The gBsyn3 or gKsyn1 recombinant viruses specifying the 216t mutation produced syncytial plaques similar in
size to the gBsyn3 or gKsyn1 viruses (Fig. 5F and L).
Plaque phenotypes of selected UL20 mutations in the context of wild-type gB and gK genes. Attempts were made to
isolate recombinant viruses specifying each of the 31 engineered UL20 mutations in the ⌬20 genetic background specifying wild-type gB and gK genes. As expected, the CL153
mutation and all of the UL20p truncations except 216t failed to
yield recombinant viruses on Vero cells. Most other UL20
mutations produced nonsyncytial virus plaques on Vero cells
that were similar in size to recombinant viruses produced by
rescuing the ⌬20 virus with the wild-type UL20 allele in agreement with initial complementation results. Interestingly, recombinant viruses containing the CL49, Y49A, and 216t mutations and which allowed complementation for virus-induced
cell fusion but exhibited deficiencies in infectious virus production were isolated (Fig. 3A and B and 4D, F, and I; Table 2).
Recombinant viruses containing the CL49, Y49A, 216t, CL209,
and R209A mutations produced partially syncytial plaques on
Vero cells (Fig. 6B1, C1, F1, G1, and H1) suggesting that
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FIG. 3. Complementation ratios of mutant UL20p genes. Vero cells were transfected with plasmids encoding wild-type or mutant UL20 genes
under the UL20 promoter and then infected with the HSV-1(KOS) UL20-null (⌬20) virus. (A) Bar graph showing complementation ratios for
UL20 cluster-to-alanine mutants and carboxyl-terminal truncations. (B) Complementation ratios of the CL49, Y49A, S50A, and R51A mutants.
(C) Complementation ratios of the CL153, E153A, T154A, S156A, and D158A mutants. (D) Complementation ratios of the CL209, R209A,
T212A, and R213A mutants. The error bars represent the maximum and minimum complementation ratios obtained from three independent
experiments, and the bar height represents the average complementation ratio.

specific UL20 domains were involved in virus-induced cell fusion. In contrast, these viruses produced nonsyncytial plaques
when plated on the G5 cells (Fig. 6B2, C2, F2, G2, and H2),
indicating that the wild-type UL20 gene expressed by G5 cells
was dominant over UL20 syncytial mutations. In the amino
terminus of UL20p, recombinants expressing the S50A and
R51A mutations, which are immediately proximal to the Y49A
and contained within the CL49 mutation, did not cause syncytial plaque formation, suggesting that mutation of the Y residue is responsible for the resultant syncytial phenotype (compare Fig. 6B1 and C1 with D1 and E1). In the carboxyl
terminus of UL20p, recombinant viruses expressing the CL209

and R209A mutations produced partially syncytial plaques on
Vero cells, while those expressing the T212A and R213A did
not (compare Fig. 5G1 and H1 with I1 and J1), suggesting that
the R residue at position 209 is responsible for the CL209
syncytial phenotype. On average, syncytia produced by recombinant viruses expressing the carboxyl-terminal syncytial mutations 216t, CL209, and R209A were larger than those produced
by the amino-terminal syncytial mutations CL49 and Y49A.
Ultrastructural characterization of recombinant viruses
carrying mutations within the amino and carboxyl termini of
UL20p. To evaluate the intracellular virion distribution of the
recombinant viruses specifying the 216t, CL49, and Y49 UL20
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TABLE 2. Complementation results for cell fusion
Mutation or
truncation

Mutations
CL5
CL11
CL16
CL23
CL30
CL34
CL38
CL41
CL46
CL49
Y49A
S50A
R51A
CL121
CL153
E153A
T154A
S156A
D158A
CL173
CL177
CL209
R209A
T212A
R213A
Truncations
66t
149t
181t
204t
211t
216t

Domain

I
I
I
I
I
I
I
I
I
I
I
I
I
III
IV
IV
IV
IV
IV
IV
IV
V
V
V
V

Extent of cell fusion by UL20-null
complementationa
gK (syn1)

gB (syn3)

⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹
⫹⫹⫹
⫹
⫹⫹
⫹⫹
⫹⫹
⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹
⫺
⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹

⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹
⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹
⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹
⫺
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹

⫺
⫺
⫺
⫺
⫺
⫹

⫺
⫺
⫺
⫺
⫺
⫹⫹⫹

a
⫺, completely absent; ⫹, very low levels of cell-fusion; ⫹⫹, moderate levels;
⫹⫹⫹, near wild-type levels; ⫹⫹⫹⫹, wild-type levels.

mutations, Vero cells infected with UL20p wild-type and mutant viruses at an MOI of 5 were examined via electron microscopy at 24 h p.i. As previously shown (17), the ⌬20 (UL20null) virus caused accumulation of unenveloped capsids into
the cytoplasm in infected Vero cells (Fig. 7A). In contrast, the
⌬20-rescued virions were transported to extracellular spaces
and exhibited no apparent cytoplasmic defects (Fig. 7B). Importantly, infection with the 216t mutant virus resulted in an
accumulation of capsids in the cytoplasm (Fig. 7C, D, E, and
F), similar to the UL20-null phenotype. Similarly, infection
with the CL49 mutant resulted in the accumulation of capsids
as well as a small percentage of enveloped particles within the
cytoplasm (Fig. 8A and B). The Y49A mutant virus produced
the same ultrastructural phenotype as the CL49 mutant (Fig.
8C). The S50A and R51A mutants exhibited no apparent defects in intracellular morphogenesis, appearing to have an intracellular distribution similar to that of the wild-type KOS
virus (Fig. 8D and E).
DISCUSSION
In this study, we constructed and characterized a panel of 31
different mutations within UL20p to delineate domains of
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UL20p functioning in virion morphogenesis and virus-induced
cell fusion. Analysis of the various mutant phenotypes reveals
that UL20p contains at least three domains involved in virion
morphogenesis and virus-induced cell fusion: the amino and
carboxyl termini of UL20 (domains I and V), which are predicted to lie on the cytoplasmic side of membranes, and UL20p
domain IV, which is predicted to lie extracellularly. Overall,
the data suggest that the role of UL20p in virus-induced cell
fusion can be functionally separated from its role in cytoplasmic virion morphogenesis and that certain UL20p domains
that function in gB-syn3-mediated virus-induced cell fusion are
distinct from those functioning in gKsyn1-mediated virus-induced cell fusion.
The predicted membrane topology of UL20p. Computerassisted prediction of the membrane-spanning domains of
UL20p indicated that UL20p spanned membranes four times
placing both the amino (domain I) and carboxyl terminal (domain V) portions within the cytoplasm of cellular membranes
and internal to the virion envelope. This predicted structure
includes two extracellular domains: a very small domain of 5
amino acids (domain II) and a second domain of 25 amino
acids (domain IV), predicted to be localized in the lumen
(extracellular) and external to the virion envelope. Initial
epitope tagging results indicate that domain I is located intracellularly, whereas domain IV is located extracellularly, which
is in support of this model (data not shown). However, additional work is required in order to fully confirm this UL20p
topology model. Domain I is the largest domain (63 amino
acids), and it includes stretches of acidic amino acid (D and E)
clusters, which could form electrostatic interactions with other
proteins. These acidic clusters as well as the amino acid motif
YXX (YSRL) have been shown to function in endocytosis of
alphaherpesvirus envelope proteins from plasma membranes
to the TGN (2, 3, 9, 40, 45). The acidic cluster motifs appear to
direct TGN localization by binding to a cellular connector
protein, PACS-1, which connects the glycoproteins to the AP-1
complex (43), while the YXX motif binds adaptor proteins
directly (2, 3, 40).
UL20p domains that function in infectious virus production
and virus-induced cell fusion. Complementation experiments
of the HSV-1(KOS) UL20-null virus, in the presence or absence of either the gBsyn3 or gKsyn1 mutations, using each
mutant UL20 gene revealed that most mutations could be
broadly categorized into four major groups based on their
differential effects on infectious virus production and virusinduced cell fusion (Table 3). Group I mutations complemented infectious virus production and virus-induced cell fusion. These mutations included CL5, CL11, CL16, CL23, and
CL30 in the amino terminus of UL20p (domain I); CL121
(domain III); CL173 and CL177 (domain IV); and CL209
(domain V). Considering that these cluster mutations involved
replacement of multiple amino acids by alanine residues, these
results indicate that the UL20p regions spanned by these mutations were not crucial for the structure and functions of
UL20p.
Group II mutations were unable to complement infectious
virus production and virus-induced cell fusion. These mutations included the CL153, 66t, 149t, 181t, 204t, and 211t mutations. The 66t, 149t and 181t mutations specify large carboxyl-terminal UL20p truncations, which are expected to
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FIG. 4. Complementation for virus-induced cell-to-cell fusion of UL20-null viruses containing syncytial mutations in gK(syn1) or gB(syn3).
Vero cells were transfected with plasmids encoding wild-type or mutant UL20 genes and then infected with either the ⌬20gKsyn1 or the ⌬20gBsyn3
viruses. At 24 h.p.i., cell fusion was determined by visualization of syncytia formation by fluorescence microscopy. The extent of syncytial formation
(complementation) obtained with the negative control plasmid, p⌬20NE (A), and positive control plasmid, p20R (B), is shown for reference
purposes. Representative images for the CL38, 204t, 211t, and 216t mutants (C, E, G, and I, respectively) and for the CL49, Y49A, S50A, and R51A
mutants (D, H, F, and J, respectively) are shown.
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drastically affect the synthesis, transport, and membrane topology of UL20p. Therefore, it is not surprising that these mutations failed to complement both infectious virus production
and virus-induced cell fusion. The 204t and 211t mutations
encode carboxyl-terminal truncations of 18 and 11 amino acids,
respectively, encompassing UL20p domain V. Although, these
deletions are rather small and not predicted to affect the membrane incorporation and topology of UL20p (not shown), they
may still affect the structure and function of UL20p. Alternatively, this UL20p carboxyl-terminal domain may be involved
in protein-protein interactions necessary for UL20p-associated
viral functions. The UL20p domain IV is predicted to lie in the
lumen or extracellular side of membranes. Based on the fact
that the CL173 and CL177 mutations complemented the
UL20-null virus, but the CL153 did not, the data suggest that
amino acids 150 to 156 are important in infectious virus production. However, none of the single amino acid changes
E153A, T154A, S156A, or D158A significantly altered
UL20p’s ability to complement the UL20-null virus, suggesting
that the combined effects of the CL153 mutations may affect
the conformation of this domain. Alternatively, this domain
may interact with luminal portions of other viral glycoproteins,
such as gB or gK, to facilitate infectious virus production and
virus-induced cell fusion.
Group III mutations included the CL49 and 216t mutations,
located at the amino and carboxyl termini of UL20p, respectively, which complemented for virus-induced cell fusion at a
reduced level, but failed to efficiently complement infectious
virus production. The carboxyl terminus of UL20p (Domain
V) is composed of 18 amino acids and predicted to localize
intracellularly. The 216t complementation results suggest that
the terminal six amino acids of UL20p are crucial for infectious
virus production. This result was further corroborated by the
recombinant virus expressing the 216t mutation, which produced an ultrastructural phenotype similar to the UL20-null
virus characterized by the accumulation of unenveloped capsids into the cytoplasm. The 216t mutation was able to complement both gBsyn3 and gKsyn1-induced cell fusion, albeit at
levels lower than those of the wild-type UL20 gene. However,
the recombinant virus carrying the 216t mutation in the
⌬20syn1 and ⌬20syn3 genetic backgrounds revealed no apparent differences in the size and extent of syncytial plaque formation in comparison to the corresponding ⌬20syn1 and
⌬20syn3 viruses expressing the wild-type UL20 allele, indicating that the UL20 216t mutation did not adversely affect virusinduced cell fusion.
The CL49 mutant phenotype in the amino terminus of
UL20p is of particular interest because alignment of the predicted amino acid sequences of multiple UL20 homologues
encoded by alphaherpesviruses revealed conservation of certain amino acid motifs within the UL20p amino terminus (not
shown). One such motif is the YXX (YSRL) amino acid
sequence overlapping the CL49 mutated sequence, which is
conserved in HSV-1, HSV-2, and cercopithecine herpesvirus 1
and 2, but not in varicella-zoster virus or pseurodabies virus
(not shown). This motif is known to function in the retrieval of
cell surface-expressed proteins to the TGN compartment (11,
26, 27, 29, 30, 42). Mutagenesis of the Y residue of a YXX
(YTKI) motif within gK domain IV, shown to lie in the cytoplasmic side of membranes, produced a gK-null phenotype
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FIG. 5. Plaque phenotypes of recombinant viruses derived from ⌬20gKsyn1 (A, B, C, D, E, and F) and ⌬20gBsyn3 (G, H, I, J, K, and L) and containing selected UL20 mutations
on Vero cells. Confluent cell monolayers were infected with the recombinant viruses containing wild-type UL20 (A and G) or the UL20 mutants CL38 (B and H), CL41 (C and
I), CL46 (D and J), CL49 (E and K), or 216t (F and L), and viral plaques were visualized by immunohistochemistry at 24 h.p.i.
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FIG. 6. Domains of UL20p associated with UL20p-induced cell fusion. Plaque phenotypes of recombinant viruses containing selected UL20 mutations are shown on Vero (A1, B1, C1, D1,
E1, F1, G1, H1, I1, and J1) and G5 (A2, B2, C2, D2, E2, F2, G2, H2, I2, and J2) cells. Confluent cell monolayers were infected with recombinant viruses containing wild-type UL20 (A1 and
A2), or the UL20 mutants CL49 (B1 and B2), Y49A (C1 and C2), S50A (D1 and D2), R51A (E1 and E2), 216t (F1 and F2), CL209 (G1 and G2), R209A (H1 and H2), T212A (I1 and I2),
or R213A (J1 and J2) at an MOI of 0.001, and viral plaques were visualized at 30 h p.i. White arrows indicate syncytia.
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(16). Similarly, site-directed mutagenesis of the Y49, S50, and
R51 residues within this motif revealed that only the Y49A
mutation caused failure to complement the UL20-null virus,
indicating that this tyrosine residue played an important role in
infectious virus production. Tyrosine residues within YXX
motifs are known to be potentially phosphorylated. Therefore,
it is possible that the Y (amino acid position 49) residue of
UL20p is phosphorylated and that this phosphorylation may be
required for proper intracellular localization and function of
UL20p. This result was further supported by the ultrastructural
phenotype of the recombinant viruses expressing the CL49 and
Y49A mutations, both of which showed an accumulation of
unenveloped capsids into the cytoplasm similar to that of the
UL20-null virus. However, the CL49 and the Y49A mutations
complemented, albeit at reduced levels, both gBsyn3- and
gKsyn1-induced cell fusion, suggesting that these mutations
only partially inactivated the UL20p functions required for
virus-induced cell fusion. This result was further supported by
the small but syncytial plaque phenotype of the recombinant
viruses expressing the CL49 mutation in either the gKsyn1 or
the gBsyn3 genetic background.
Group IV mutations exhibited a variable effect on virusinduced cell fusion but did not drastically reduce infectious
virus production. Specifically, the CL38 UL20 mutant gene
complemented virus-induced cell fusion caused by the
⌬20gBsyn3 and ⌬20gKsyn1 viruses at low levels, while the
CL41 and CL46 mutant genes complemented ⌬20gKsyn1 at
low levels but ⌬20gBsyn3 at high levels and levels equivalent to
the complementation levels produced with the wild-type UL20
gene. The initial complementation results were further supported by the recombinant viruses carrying either the CL41 or
the CL46 mutation in the gKsyn1 or gBsyn3 genetic background. Specifically, the gKsyn1 recombinants carrying either
the CL41 or CL46 mutations produced small syncytial plaques,
while the gBsyn3 recombinants carrying either the CL41 or
CL46 mutations produced large syncytial virus plaques indistinguishable to the gBsyn3 recombinant virus carrying the wildtype UL20 allele. These results suggest that the UL20p aminoterminal domain demarcated by the CL38 to CL46 mutations
is important in virus-induced cell fusion; however, the specific
amino acid requirements within this domain may be different
for gBsyn3 versus gKsyn1-induced cell fusion.
UL20p mutations that cause virus-induced cell fusion.
Characteristically, recombinant viruses expressing the CL49,
Y49A, CL209, R209A, and 216t UL20p mutations in a wildtype genetic background formed small syncytial plaques on
Vero cells. Recombinant viruses specifying the T212A and
R213A mutations did not produce syncytial plaques on Vero
cells, indicating that the R209A mutation was responsible for
the syncytial phenotype of the CL209 mutation. Thus, it is
evident that the amino and carboxyl termini of UL20p are
directly associated with virus-induced cell fusion in the context
of wild-type gB or gK expression. Therefore, the ability of
these mutations to complement either gBsyn3 or gKsyn1 virusinduced cell fusion discussed earlier may be in part due to the
inherent fusogenic character of the mutated UL20p. Most
likely, this is not the case because recombinant viruses carrying
the UL20 R209A syncytial mutation as well as either the
gBsyn3 or the gKsyn1 mutation did not exhibit increased virusinduced cell fusion in comparison to viruses specifying either

Downloaded from https://journals.asm.org/journal/jvi on 18 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

VOL. 78, 2004

MELANCON ET AL.

J. VIROL.

FIG. 7. Electron micrographs of Vero cells infected with ⌬20DIV5 (A), ⌬20-rescue (B), or 216t (C, D, E, and F) viruses. Confluent cell
monolayers were infected at an MOI of 5, incubated at 37°C for 24 h, and prepared for TEM. Panel D shows a higher magnification of panel C.
Panel F shows a partially enveloped capsid often seen in UL20-null-infected cells. Nuclear (n), cytoplasmic (c), and extracellular (e) spaces are
marked.
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FIG. 8. Electron micrographs of Vero cells infected with the CL49 (A and B), Y49〈 (C), S50A (D), or R51A (E) viruses. Confluent cell
monolayers were infected at an MOI of 5, incubated at 37°C for 24 h, and prepared for TEM. Nuclear (n), cytoplasmic (c), and extracellular (e)
spaces are marked.

TABLE 3. Differential effects of mutations on infectious virus production and cell fusion
Group

I
II
III
IV

Mutants

CL5, CL11, CL16, CL23, CL30, CL34,
CL121, CL173, CL177, CL209
CL153, 66t, 149t, 181t, 204t, 211t
CL49, 216t
CL38, CL41, CL46

Complementation for
infectious virion
production

gKsyn1

Yes

High

High

No
No
Yes

No
Low
Low

No
Low (CL49) High (216t)
Low (CL38) High (CL41, CL46)

Complementation for virus-induced cell fusion
gBsyn3
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the gBsyn3 or gKsyn1 mutation and the wild-type UL20 gene
(not shown). Alternatively, UL20p may function as a regulator
of virus-induced cell fusion through interactions with other
viral proteins such as gB and gK, and disruption of these
interactions by specific UL20p mutations may result in the
formation of syncytia.
Deletion of the gK gene or lethal gK mutation causes entrapment of enveloped virions within cytoplasmic vesicles presumably originating from the TGN compartment and the accumulation of unenveloped capsids in the cytoplasm (16, 24).
Similarly, deletion of the UL20 gene or lethal UL20p mutations cause accumulation of unenveloped capsids into the cytoplasm and a small portion of enveloped capsids within cytoplasmic vesicles (17, 18). These results suggest that UL20p and
gK may have interrelated functions with regard to cytoplasmic
virion envelopment. The fact that the Y49A, CL49, and 216t
mutant viruses produced syncytial plaques, although their ultrastructural phenotypes seemed to be similar to that of the
UL20-null virus, suggests that UL20 functions for virus-induced cell fusion may be distinct from those functioning in
cytoplasmic virion envelopment. Alternatively, the same domains may function in both cytoplasmic virion envelopment
and virus-induced cell fusion; however, virion envelopment
may be more susceptible to the negative effects of these mutations than to virus-induced cell fusion.
Overall, our previous findings and the results presented in
this paper suggest the existence of functional interactions between gK and UL20p as well as between UL20p and gB. In this
regard, it is interesting that syncytial mutations in gB lie in the
intracellular carboxyl terminus of gB, allowing the possibility
that intracellular domains of UL20p (domains I and V) directly
or indirectly interact with the carboxyl terminus of gB altering
gB’s fusogenic properties.
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